ES357611A1 - Un procedimiento para la produccion de una composicion paraadministracion oral a un paciente antes del examen radiolo- gico. - Google Patents
Un procedimiento para la produccion de una composicion paraadministracion oral a un paciente antes del examen radiolo- gico.Info
- Publication number
- ES357611A1 ES357611A1 ES357611A ES357611A ES357611A1 ES 357611 A1 ES357611 A1 ES 357611A1 ES 357611 A ES357611 A ES 357611A ES 357611 A ES357611 A ES 357611A ES 357611 A1 ES357611 A1 ES 357611A1
- Authority
- ES
- Spain
- Prior art keywords
- cellulose
- composition
- polyhydric alcohol
- parts
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000001913 cellulose Substances 0.000 abstract 6
- 229920002678 cellulose Polymers 0.000 abstract 6
- 150000001875 compounds Chemical class 0.000 abstract 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- 150000005846 sugar alcohols Polymers 0.000 abstract 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 abstract 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 abstract 1
- 241000555825 Clupeidae Species 0.000 abstract 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-WHZQZERISA-N D-aldose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-WHZQZERISA-N 0.000 abstract 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 abstract 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 abstract 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 abstract 1
- 239000004386 Erythritol Substances 0.000 abstract 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- 239000001856 Ethyl cellulose Substances 0.000 abstract 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 abstract 1
- 229930091371 Fructose Natural products 0.000 abstract 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 abstract 1
- 239000005715 Fructose Substances 0.000 abstract 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-VSOAQEOCSA-N L-altropyranose Chemical compound OC[C@@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-VSOAQEOCSA-N 0.000 abstract 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 abstract 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 abstract 1
- 150000001298 alcohols Chemical class 0.000 abstract 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 abstract 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 abstract 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 abstract 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 238000004945 emulsification Methods 0.000 abstract 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 abstract 1
- 235000019414 erythritol Nutrition 0.000 abstract 1
- 229940009714 erythritol Drugs 0.000 abstract 1
- 235000019325 ethyl cellulose Nutrition 0.000 abstract 1
- 229920001249 ethyl cellulose Polymers 0.000 abstract 1
- 235000010944 ethyl methyl cellulose Nutrition 0.000 abstract 1
- 229930182830 galactose Natural products 0.000 abstract 1
- 230000036571 hydration Effects 0.000 abstract 1
- 238000006703 hydration reaction Methods 0.000 abstract 1
- -1 hydroxy- Chemical class 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 abstract 1
- 229920000609 methyl cellulose Polymers 0.000 abstract 1
- 239000001923 methylcellulose Substances 0.000 abstract 1
- 235000010981 methylcellulose Nutrition 0.000 abstract 1
- 229920003087 methylethyl cellulose Polymers 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 150000003385 sodium Chemical class 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0404—X-ray contrast preparations containing barium sulfate
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA613 | 1967-09-21 | ||
| US73062268A | 1968-05-20 | 1968-05-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES357611A1 true ES357611A1 (es) | 1970-05-01 |
Family
ID=25665751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES357611A Expired ES357611A1 (es) | 1967-09-21 | 1968-08-28 | Un procedimiento para la produccion de una composicion paraadministracion oral a un paciente antes del examen radiolo- gico. |
Country Status (6)
| Country | Link |
|---|---|
| BE (1) | BE721206A (cs) |
| CH (1) | CH494575A (cs) |
| ES (1) | ES357611A1 (cs) |
| FR (1) | FR7928M (cs) |
| GB (1) | GB1233567A (cs) |
| NL (1) | NL6813175A (cs) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1977768A1 (en) * | 2007-04-04 | 2008-10-08 | GC Corporation | Dental paste composition having X-Ray imaging property |
-
1968
- 1968-08-28 ES ES357611A patent/ES357611A1/es not_active Expired
- 1968-09-12 GB GB1233567D patent/GB1233567A/en not_active Expired
- 1968-09-13 NL NL6813175A patent/NL6813175A/xx unknown
- 1968-09-20 BE BE721206D patent/BE721206A/xx unknown
- 1968-09-20 FR FR167038A patent/FR7928M/fr not_active Expired
- 1968-10-20 CH CH1409368A patent/CH494575A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR7928M (cs) | 1970-05-19 |
| GB1233567A (cs) | 1971-05-26 |
| CH494575A (fr) | 1970-08-15 |
| NL6813175A (cs) | 1969-03-25 |
| BE721206A (cs) | 1969-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4198391A (en) | Pharmaceutical compositions | |
| ES424533A1 (es) | Metodo de prolongar la disponibilidad de sustancias farmaco-logicamente activas incluidas en composiciones farmaceuticasa base de alcohol alifatico e hidroxialcohilcelulosa. | |
| KR850000975A (ko) | 발프로익산과 그 염의 혼합물을 토대로 한 조성물 | |
| KR840000228A (ko) | 조제성 혼합물에 있어서 건성분말의 제조방법 | |
| JPS62281892A (ja) | エストラジオ−ル−１７β−エステル | |
| ES308585A1 (es) | Metodo de preparacion de una tableta analgesica. | |
| MY102980A (en) | Transdermal flux enhancing compositions | |
| KR880002515A (ko) | 흡수 및 작용이 빠른 설린다크 또는 나트륨 설린다크와 염기의 혼합물 | |
| KR930001912A (ko) | 개선된 디데옥시 퓨린 뉴클레오사이드 경구 투여 제제 | |
| ES469878A1 (es) | Un procedimiento para preparar una composicion farmaceutica para el tratamiento del habito de consumir drogas | |
| ES380943A1 (es) | Un procedimiento para preparar una composicion anastesica adecuada para administracion parenteral. | |
| Larhsini et al. | The antipyretic activity of some Moroccan medicinal plants | |
| ES370058A1 (es) | Procedimiento para la preparacion de composiciones farma- ceuticas efervescentes. | |
| ES357611A1 (es) | Un procedimiento para la produccion de una composicion paraadministracion oral a un paciente antes del examen radiolo- gico. | |
| KR890003752A (ko) | 2-피리미디닐-피페라딘 유도체의 용도 | |
| CA1095411A (en) | Cardiotonic gelatin capsules | |
| KR900014385A (ko) | 제약학적 치료 | |
| Ivy et al. | Obligatory function of a continuous flow of normal bile for cholesterol absorption | |
| CA1046410A (en) | Cardiotonic composition | |
| ATE1066T1 (de) | Aminopropanolderivate des 6-hydroxy-2,3,4,5-tetrahy dro-1h-1-benzazepin-2-ons, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
| JPS5244682A (en) | Direct reading type ray absorbed dose rate measuring apparatus | |
| EP0414688A1 (en) | PROCESS FOR REGULATING THE SPEED OF ABSORPTION OF MEDICINES AND PHARMACEUTICAL COMPOSITION. | |
| US3689654A (en) | Pharmaceutical compositions | |
| KR830009776A (ko) | 세포 보호 유도방법 | |
| KR860000070A (ko) | 종양 발육억제 조성물 |